131 related articles for article (PubMed ID: 12230936)
81. Single genome amplification and standard bulk PCR yield HIV-1 envelope products with similar genotypic and phenotypic characteristics.
Etemad B; Ghulam-Smith M; Gonzalez O; White LF; Sagar M
J Virol Methods; 2015 Mar; 214():46-53. PubMed ID: 25681527
[TBL] [Abstract][Full Text] [Related]
82. Immunological characteristics of the putative CD4-binding site of the HIV-1 envelope protein.
Kieber-Emmons T; Krowka JF; Boyer J; Ugen KE; Williams WV; Morrow WJ; Weiner DB
Pathobiology; 1992; 60(4):187-94. PubMed ID: 1388715
[TBL] [Abstract][Full Text] [Related]
83. IFN-gamma restores HIV- and non-HIV-specific cell mediated immune response in vitro and its activity is neutralized by antibodies from patients with AIDS.
De Francesco MA; Caruso A; Dima F; Cantalamessa A; Canaris AD; Folghera S; Fiorentini S; Flamminio G; Licenziati S; Peroni L; Gao J; Garotta G; Turano A
Scand J Immunol; 1996 Jan; 43(1):94-100. PubMed ID: 8560203
[TBL] [Abstract][Full Text] [Related]
84. The genome of herpesvirus saimiri C488 which is capable of transforming human T cells.
Ensser A; Thurau M; Wittmann S; Fickenscher H
Virology; 2003 Sep; 314(2):471-87. PubMed ID: 14554077
[TBL] [Abstract][Full Text] [Related]
85. Comparison of viral burden and phenotype of HIV-1 isolates from lymph nodes and blood.
Tamalet C; Lafeuillade A; Yahi N; Vignoli C; Tourres C; Pellegrino P; de Micco P
AIDS; 1994 Aug; 8(8):1083-8. PubMed ID: 7986403
[TBL] [Abstract][Full Text] [Related]
86. T cell activation antigen, CD26, as a cofactor for entry of HIV in CD4+ cells.
Callebaut C; Krust B; Jacotot E; Hovanessian AG
Science; 1993 Dec; 262(5142):2045-50. PubMed ID: 7903479
[TBL] [Abstract][Full Text] [Related]
87. Human monoclonal antibodies to HIV-1 define synergistic activities leading to enhanced neutralization.
Zolla-Pazner S; Laal S; Burda S; Buchbinder A
Antibiot Chemother (1971); 1994; 46():38-47. PubMed ID: 7826038
[No Abstract] [Full Text] [Related]
88. Complement-mediated enhancement of HIV-1 infection in peripheral blood mononuclear cells.
Nielsen SD; Sørensen AM; Schønning K; Lund O; Nielsen JO; Hansen JE
Scand J Infect Dis; 1997; 29(5):447-52. PubMed ID: 9435030
[TBL] [Abstract][Full Text] [Related]
89. Herpes virus saimiri transformation of T cells in CD3 gamma immunodeficiency: phenotypic and functional characterization.
Rodríguez-Gallego C; Corell A; Pacheco A; Timón M; Regueiro JR; Allende LM; Madroño A; Arnaiz-Villena A
J Immunol Methods; 1996 Nov; 198(2):177-86. PubMed ID: 8946013
[TBL] [Abstract][Full Text] [Related]
90. Generation of herpes virus saimiri-transformed T-cell lines from macaques is restricted by reactivation of simian spuma viruses.
Feldmann G; Fickenscher H; Bodemer W; Spring M; Niblein T; Hunsmann G; Dittmer U
Virology; 1997 Mar; 229(1):106-12. PubMed ID: 9123851
[TBL] [Abstract][Full Text] [Related]
91. Detection of HIV-1 infection in vitro using NASBA: an isothermal RNA amplification technique.
Romano JW; Shurtliff RN; Sarngadharan MG; Pal R
J Virol Methods; 1995 Aug; 54(2-3):109-19. PubMed ID: 8530563
[TBL] [Abstract][Full Text] [Related]
92. Design, development, and interpretation of HIV neutralization assays.
Whalley AS; Nguyen ML; Morrow WJ
Viral Immunol; 1991; 4(4):201-13. PubMed ID: 1726397
[TBL] [Abstract][Full Text] [Related]
93. Mutation of herpesvirus Saimiri ORF51 glycoprotein specifically targets infectivity to hepatocellular carcinoma cell lines.
Turrell SJ; Whitehouse A
J Biomed Biotechnol; 2011; 2011():785158. PubMed ID: 21197456
[TBL] [Abstract][Full Text] [Related]
94. Replication of Herpesvirus saimiri is semipermissive in human cells because of a block in the synthesis of certain late proteins.
Dahlberg JE; Ablashi DV; Rhim JS; Fladger A; Salahuddin SZ
Intervirology; 1988; 29(4):277-34. PubMed ID: 2846468
[TBL] [Abstract][Full Text] [Related]
95. Detection of antibodies to Herpesvirus saimiri late antigens in human sera.
Ablashi DV; Dahlberg JE; Cannon GB; Fischetti G; Loeb W; Hinds W; Schatte C; Levine PH
Intervirology; 1988; 29(4):217-26. PubMed ID: 2846466
[TBL] [Abstract][Full Text] [Related]
96. Generation of CD4+ and CD8+ T-cell clones from PBLs of HIV-1 infected subjects using herpesvirus saimiri.
Saha K; Sova P; Chao W; Chess L; Volsky DJ
Nat Med; 1996 Nov; 2(11):1272-5. PubMed ID: 8898759
[No Abstract] [Full Text] [Related]
97. Stable growth transformation of human T lymphocytes by herpesvirus saimiri.
Biesinger B; Müller-Fleckenstein I; Simmer B; Lang G; Wittmann S; Platzer E; Desrosiers RC; Fleckenstein B
Proc Natl Acad Sci U S A; 1992 Apr; 89(7):3116-9. PubMed ID: 1313581
[TBL] [Abstract][Full Text] [Related]
98. Single-round HIV type 1 neutralization measured by ELISPOT technique in primary human cells.
Patiris P; Hanson C
AIDS Res Hum Retroviruses; 2005 Sep; 21(9):784-90. PubMed ID: 16218802
[TBL] [Abstract][Full Text] [Related]
99. Nononcogenic deletion mutants of herpesvirus saimiri are defective for in vitro immortalization.
Desrosiers RC; Silva DP; Waldron LM; Letvin NL
J Virol; 1986 Feb; 57(2):701-5. PubMed ID: 3003401
[TBL] [Abstract][Full Text] [Related]
100. HIV neutralization assay using polymerase chain reaction-derived molecular signals.
Robb ML; Polonis V; Vahey M; Gartner S; Michael N; Fowler A; Redfield RR
J Acquir Immune Defic Syndr (1988); 1992 Dec; 5(12):1224-9. PubMed ID: 1453333
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
